Literature DB >> 23818152

The glutamate system as a therapeutic target and impact of genes on suicidality.

Andrea Schmitt, Peter Falkai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23818152     DOI： 10.1007/s00406-013-0418-z

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  9 in total

1.  Twin-based study of the complex interplay between childhood maltreatment, socioeconomic status and adult memory.

Authors:  Ximena Goldberg; Silvia Alemany; Mar Fatjó-Vilas; Itxaso González-Ortega; Ana González-Pinto; Manuel J Cuesta; Lourdes Fañanás
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-28       Impact factor: 5.270

2.  Trends in suicidality amid the economic crisis in Greece.

Authors:  Konstantinos N Fountoulakis; Christos Savopoulos; Melina Siamouli; Eleni Zaggelidou; Stamatia Mageiria; Apostolos Iacovides; Apostolos I Hatzitolios
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-12-06       Impact factor: 5.270

Review 3.  Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders.

Authors:  Kenji Hashimoto; Berend Malchow; Peter Falkai; Andrea Schmitt
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-01       Impact factor: 5.270

4.  No influence of brain-derived neurotrophic factor (BDNF) polymorphisms on treatment response in a naturalistic sample of patients with major depression.

Authors:  Richard Musil; Peter Zill; Florian Seemüller; Brigitta Bondy; Michael Obermeier; Ilja Spellmann; Wolfram Bender; Mazda Adli; Isabella Heuser; Joachim Zeiler; Wolfgang Gaebel; Wolfgang Maier; Marcella Rietschel; Dan Rujescu; Rebecca Schennach; Hans-Jürgen Möller; Michael Riedel
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-11       Impact factor: 5.270

5.  Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4T.

Authors:  Gagan Joshi; Joseph Biederman; Janet Wozniak; Rachel L Goldin; Dave Crowley; Stephannie Furtak; Scott E Lukas; Atilla Gönenç
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-09-18       Impact factor: 5.270

6.  Factors predicting the long-term illness course in a cohort of depressed inpatients.

Authors:  Christine Kuehner; Silke Huffziger
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-30       Impact factor: 5.270

7.  Mortality of 403 patients with mood disorders 48 to 52 years after their psychiatric hospitalisation.

Authors:  Jules Angst; Michael P Hengartner; Alex Gamma; Detlev von Zerssen; Felix Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-11-04       Impact factor: 5.270

8.  MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls.

Authors:  Niki Antypa; Ina Giegling; Raffaella Calati; Barbara Schneider; Annette M Hartmann; Marion Friedl; Bettina Konte; Loredana Lia; Diana De Ronchi; Alessandro Serretti; Dan Rujescu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-31       Impact factor: 5.270

9.  The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder.

Authors:  Peter Höfer; Alexandra Schosser; Raffaella Calati; Alessandro Serretti; Isabelle Massat; Neslihan Aygun Kocabas; Anastasios Konstantinidis; Sylvie Linotte; Julien Mendlewicz; Daniel Souery; Joseph Zohar; Alzbeta Juven-Wetzler; Stuart Montgomery; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-10-19       Impact factor: 5.270
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.